TIEYVT Trademark

Trademark Overview


On Friday, December 11, 2020, a trademark application was filed for TIEYVT with the United States Patent and Trademark Office. The USPTO has given the TIEYVT trademark a serial number of 90375188. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by Eli Lilly and Company. The TIEYVT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
tieyvt

General Information


Serial Number90375188
Word MarkTIEYVT
Filing DateFriday, December 11, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 2 FILED
Wednesday, October 12, 2022TEAS EXTENSION RECEIVED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 1 FILED
Monday, April 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 7, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 7, 2021NON-FINAL ACTION WRITTEN
Thursday, June 3, 2021ASSIGNED TO EXAMINER
Thursday, February 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 15, 2020NEW APPLICATION ENTERED